Canadian health authorities have issued a precautionary recall for masks containing graphene—a nanomaterial made up of a single layer of carbon atoms—citing the need to study health risks after a study in animals found the substance had “some potential” to cause lung toxicity.
The advisory cites research showing that inhaled graphene particles “had some potential to cause early lung toxicity in animals” although it noted that the health risk to humans is still unknown and requires further study.
Health Canada said it is working with manufacturers of the masks to assess their potential impact on people’s health.
“Until the Department completes a thorough scientific assessment and has established the safety and effectiveness of graphene-containing face masks, it is taking the precautionary approach of removing them from the market while continuing to gather and assess information,” the agency said.
Mask design may affect the potential to inhale the graphene particles, while other variables, like the type of graphene used and the amount and duration of exposure to the substance, all have a likely impact on the health risk, Health Canada said.
Health Canada noted that the substance has been reported to have antiviral and antibacterial properties, adding that some graphene-containing masks “with COVID-19 claims” have been sold on the Canadian market, although it did not provide specifics as to the claims.
According to the release, the City University of Hong Kong research team is working with laboratories in mainland China to test the graphene material with two species of human coronaviruses.
“Initial tests showed that it inactivated over 90 [percent] of the virus in five minutes and almost 100 [percent] in 10 minutes under sunlight. The team plans to conduct testings with the COVID-19 virus later,” the release noted.